Search Results
Chronic Kidney Disease -- The Oxford Renal Study
Jenny Hirst NewKI Chronic Kidney Disease Study
EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths
Chronic Kidney Disease - lecture by Dr Dan Lasserson
EMPA-KIDNEY: meta-analysis results
The London Kidney Network: Identifying, Coding and Managing Chronic Kidney Disease (9 March 2023)
Emerging data from EMPA-KIDNEY study
EMPA KIDNEY results: Flozins for all CKD with Dr Will Herrington
EMPA-KIDNEY: Introduction to the trial
Chronic Kidney Disease: Breaking Barriers with Cardiovascular & Renal Integration in Clinical Trials
IgA Nephropathy
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease
